Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies

Authors:

Abstract
Reduced CYP2D6 metabolism and low Z-endoxifen (ENDX) concentrations may increase the risk of breast cancer recurrence in tamoxifen (TAM)-treated women. Little is known regarding the differences between TAM and ENDX murine pharmacokinetics or the effect of administration route on plasma concentrations of each drug.

This publication has 32 references indexed in Scilit: